Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nephros (NEPH) Net Cash Flow (2016 - 2025)

Historic Net Cash Flow for Nephros (NEPH) over the last 17 years, with Q3 2025 value amounting to $97000.0.

  • Nephros' Net Cash Flow rose 11556.98% to $97000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.7 million, marking a year-over-year increase of 23034.68%. This contributed to the annual value of -$555000.0 for FY2024, which is 18246.66% down from last year.
  • According to the latest figures from Q3 2025, Nephros' Net Cash Flow is $97000.0, which was up 11556.98% from $993000.0 recorded in Q2 2025.
  • Nephros' 5-year Net Cash Flow high stood at $1.3 million for Q4 2024, and its period low was -$1.5 million during Q1 2022.
  • Its 5-year average for Net Cash Flow is -$155157.9, with a median of -$239000.0 in 2022.
  • As far as peak fluctuations go, Nephros' Net Cash Flow plummeted by 181358.02% in 2022, and later skyrocketed by 56920.29% in 2024.
  • Over the past 5 years, Nephros' Net Cash Flow (Quarter) stood at -$372000.0 in 2021, then increased by 17.74% to -$306000.0 in 2022, then grew by 9.8% to -$276000.0 in 2023, then soared by 569.2% to $1.3 million in 2024, then tumbled by 92.51% to $97000.0 in 2025.
  • Its last three reported values are $97000.0 in Q3 2025, $993000.0 for Q2 2025, and $321000.0 during Q1 2025.